Medical Science Liaison — Solid Tumors (Poland)

Biopharma Careers; Warszawa; On-site; PLN 186,000 - 299,000; Full time

Benefits offered by this job

Annual bonus

Vacation days

Parental leave

Bereavement leave

Well-being reimbursement

Insurance plans

Job summary

Johnson & Johnson is seeking a Medical Science Liaison for solid tumors, based in Warsaw or Lodz. The MSL will maximize the value of products through scientific dialogue with Leading Specialists and work within the Medical Affairs Plan.

You will build a network among physicians, pharmacists, hospital managers and society leaders, provide scientific support to sales, and help with study execution and advisory boards while ensuring non-promotional interactions.

Qualifications

• Medical Doctor or Pharmaceutical/Natural Sciences degree required.
• Minimum 2 years of relevant experience in medical affairs or related field.
• Strong scientific communication skills and ability to engage Leading Specialists.
• Fluency in English and Polish is essential.

Responsibilities

• Maximize value of products through scientific dialogue with Leading Specialists.
• Provide input to Medical Affairs Plan and collaborate with cross-functional teams.
• Develop and maintain a network of Leading Specialists and advisory boards.
• Support Medical Affairs and GCO in study execution and data generation projects.
• Ensure interactions are non-promotional and compliant with regulations.

Skills

Scientific knowledge

Communication

Customer focus

Fluent English

Fluent Polish

Driving license

Education

Medical Doctor

Pharmaceutical/Natural Sciences degree

Job description

Johnson & Johnson is seeking a Medical Science Liaison for solid tumors, based in Warsaw or Lodz. The MSL will maximize the value of products through scientific dialogue with Leading Specialists and work within the Medical Affairs Plan.

You will build a network among physicians, pharmacists, hospital managers and society leaders, provide scientific support to sales, and help with study execution and advisory boards while ensuring non-promotional interactions.